Transgene Biotek Limited (BOM:526139)

Transgene Biotek Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 16, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	185	254	617	189	274	347
Market Cap Growth	-51.30%	-58.85%	226.91%	-31.03%	-21.18%	52.16%
Enterprise Value	349	393	752	314	390	455
Last Close Price	2.44	3.35	8.14	2.49	3.61	4.58
PS Ratio	72.42	97.37	262.57	342.41	315.51	204.68
PB Ratio	2.01	2.53	5.76	1.66	1.57	1.56
P/TBV Ratio	6.93	-	-	3.92	4.59	32.15
P/FCF Ratio	-	-	13408.00	-	279.68	-
P/OCF Ratio	16.40	21.23	13408.00	94333.65	279.68	2761.19
EV/Sales Ratio	136.83	150.87	320.27	569.87	449.30	268.54
EV/FCF Ratio	-61.04	-	16354.75	-	398.27	-
Debt / Equity Ratio	1.79	1.45	1.31	1.15	0.69	0.51
Debt / FCF Ratio	-	-	3043.70	-	122.78	-
Asset Turnover	0.00	0.00	0.00	0	0.00	0.00
Inventory Turnover	-	-	0.09	1.03	-	2.18
Quick Ratio	0.01	0.02	0.00	0.00	0.00	0.00
Current Ratio	0.08	0.10	0.10	0.10	0.08	0.05
Return on Equity (ROE)	-16.21%	-6.52%	-5.94%	-41.80%	-52.51%	-38.00%
Return on Assets (ROA)	-0.43%	-0.53%	-0.31%	-2.59%	-4.27%	-4.03%
Return on Invested Capital (ROIC)	-2.46%	-3.08%	-1.77%	-13.93%	-20.62%	-17.03%
Return on Capital Employed (ROCE)	-0.80%	-0.90%	-0.50%	-4.60%	-7.50%	-7.30%
Earnings Yield	-8.79%	-2.66%	-1.06%	-31.85%	-38.03%	-30.07%
FCF Yield	-3.10%	-1.98%	0.01%	-0.01%	0.36%	-0.04%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.